Article
SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
2018-12-17
Abstract excerpt
<h4>Purpose: </h4> Up to 30-40% of Ewing sarcoma (EwS) patients with non-metastatic disease develop local or metastatic relapse within a time range of 2-10 years. This is in part caused by the absence of prognostic biomarkers that can identify high-risk patients to assign them to risk-adapted monitoring and treatment regimens. Since cancer stemness has been associated with tumor relapse and poor outcome, we invest...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3bc33ffe-1eb4-520b-a193-9ac37d8433b3
- DOI
- 10.1101/498253
